Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Effects of Fenofibrate Adjuvant Therapy Versus Conventional Phototherapy in Treatment of Neonatal Exaggerated Hyperbilirubinemia.

NCT06346743 is registered in ClinicalTrials.gov with Muhammad Zark as lead sponsor.

NCT NCT06346743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06346743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Effects of Fenofibrate Adjuvant Therapy Versus Conventional Phototherapy in Treatment of Neonatal Exaggerated Hyperbilirubinemia.
Lead sponsor
Muhammad Zark
Phase
Phase 2/3
Overall status
Unknown status
Start date
April 30, 2024
Completion date
August 31, 2024
Enrollment
156 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

physiological hyperbilirubinaemia, physiological neonatal jaundice